Impact of a Nurse Navigator on Genomic Testing and Timely Treatment Decision Making in Patients With Breast Cancer

Kelly A. McAllister, RN, BSN, OCN, CBCN; Mary L. Schmitt, MS, APRN, FNP-BC, AOCNP


Clin J Oncol Nurs. 2015;19(5):510-512. 

In This Article

Evaluation and Limitations

The RN navigator tracked all turnaround times and provider compliance with NCCN guidelines. The information was reported quarterly at the institution's cancer committee meetings and annually during the Commission on Cancer accreditation review.

Limitations included the inability to bill for these navigation services; however, the benefits to patients outweighed this limitation. The patient identification and tracking process was manual and time consuming; however, the implementation of a new electronic medical record may be an opportunity to improve efficiency.